Generation of an induced pluripotent stem cell (iPSC) line from a patient with GEFS+ carrying a STX1B (p.Lys45delinsArgMetCysIleGlu and p.Leu46Met) mutation

Stem Cell Res. 2023 Mar:67:103028. doi: 10.1016/j.scr.2023.103028. Epub 2023 Jan 13.

Abstract

The STX1B gene encodes the presynaptic protein syntaxin-1B, which plays a major role in regulating fusion of synaptic vesicles. Mutations in STX1B are known to cause epilepsy syndromes, such as genetic epilepsies with febrile seizures plus (GEFS+). Here, we reprogrammed skin fibroblasts from a female patient affected by GEFS+ to human induced pluripotent stem cells (iPSCs). The patient carries an InDel mutation (c.133_134insGGATGTGCATTG; p.Lys45delinsArgMetCysIleGlu and c.135_136AC > GA; p.Leu46Met), located in the regulatory Habc-domain of STX1B. Successful reprogramming of cells was confirmed by a normal karyotype, expression of several pluripotency markers and the potential to differentiate into all three germ layers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Epilepsy* / genetics
  • Female
  • Fibroblasts
  • Humans
  • INDEL Mutation
  • Induced Pluripotent Stem Cells* / metabolism
  • Mutation
  • Syntaxin 1 / genetics
  • Syntaxin 1 / metabolism

Substances

  • STX1B protein, human
  • Syntaxin 1